-

CLIA - Clinical Laboratory Improvement Amendments

Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA
 

New Search Back To Search Results
Test System NameLuminex 100 Integrated System  {xTAG Cystic Fibrosis 39 Kit v2} 
Document Number K083846
Analyte NameCFTR (cystic fibrosis transmembrane conductance regulator) mutations
Analyte SpecialtyGeneral Immunology
ComplexityHIGH
Effective Date09/09/2009
Device Classification Name system, cystic fibrosis transmembrane conductance regulator, gene mutation detection
510(k) NumberK083846
Device NameXTAG CYSTIC FIBROSIS 39 KIT V2, (CFTR 39 KIT V2), MODEL I027C0231, I027D0266, I027E0267
Applicant
LUMINEX MOLECULAR DIAGNOSTICS, INC.
439 university ave.
toronto, ontario, 
Contactgloria lee
Regulation Number866.5900
Classification Product Code
NUA  
Date Received12/24/2008
Decision Date 09/01/2009
Decision substantially equivalent - CLIA submission (CS)
Classification Advisory Committee Immunology
Review Advisory Committee Immunology
Statement/Summary/Purged Status Summary only
summary summary
FDA Review Decision Summary
Type Traditional
Reviewed by Third Party No
Expedited Review No
 
-
-
-
-
-